Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Singular Genomics Systems, Inc. (OMIC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.0900+0.2300 (+8.04%)
At close: 04:00PM EDT
3.0900 0.00 (0.00%)
After hours: 04:38PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.1300
Open3.3200
Bid2.6400 x 2900
Ask3.0800 x 800
Day's Range2.9500 - 3.3300
52 Week Range2.8500 - 33.3700
Volume1,660,878
Avg. Volume563,552
Market Cap222.661M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.7500
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.50
  • Motley Fool

    3 Biotech Stocks With a Cash Pile Higher Than Their Valuations

    Biotech companies spend a lot of money. They spend it on research and development, clinical trials, and (if they are lucky) marketing and a salesforce. Bringing a new pharmaceutical or medical device to market is an expensive proposition.

  • GlobeNewswire

    Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results

    LA JOLLA, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the quarter ended March 31, 2022. “We are on track to begin shipping G4 instruments to our customers in the second quarter. We are encouraged by the robust external validation through our Bet

  • GlobeNewswire

    Singular Genomics Collaborates with NVIDIA to Deliver Market-Leading Next-Generation Sequencing and Analysis Speeds

    Singular’s G4 Sequencing Platform with NVIDIA Clara Parabricks secondary analysis tools delivers accelerated results for prominent applications including whole genome sequencingLA JOLLA, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the company is collaborating with NVIDIA to validate and optimize the performance

Advertisement
Advertisement